メインコンテンツにスキップ

サターラ、Nancy KilleferとCynthia Collinsを新しい社外取締役に任命

ニュージャージー州プリンストン 2021年7月15日: Certara, a global leader in biosimulation, today announced the appointments of Nancy Killefer and Cynthia Collins to its board of directors, effective 2021年8月1日.  The two additional appointments increase the company’s board of directors to eleven members. “It’s truly a pleasure to welcome Nancy and Cynthia to the board … Continued

サターラ、2021年第2四半期の業績を2021年8月5日に発表予定

PRINCETON, N.J.— 2021年7月14日– Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of 2021 after the market close on 2021年8月5日 (木曜日). Company management will host a conference call to discuss financial results at 5:00 p.m. ET. Investors interested in … Continued

Certara Announces New Chief Human Resources Officer

Veteran HR leader brings 20+ years of human resources experience to the company’s executive team PRINCETON, N.J.— 2021年7月13日. Certara®, a global leader in biosimulation, today announced that it has appointed Nicolette D. Sherman to the position of Chief Human Resources Officer (CHRO). Sherman joins Certara with extensive experience in the biopharmaceutical industry, leading … Continued

Certara Recognized by NJBIZ as One of New Jersey’s Best Places to Work

ニュージャージー州プリンストン 2021年6月29日: Certara, the global leader in biosimulation, today announced that it has been recognized as one of the “Best Places to Work” in New Jersey in 2021 by NJBIZ, one of New Jersey’s leading business journals. Certara is headquartered in Princeton, N.J. “We are honored to be named one of the … Continued

サターラ社、Dr. Carol Gallagherを新たなIndependent Board Memberに任命

Dr. Gallagher brings more than 30 years of drug development and commercial leadership experience to her new role PRINCETON, N.J.—2021年6月14日.  Certara, a global leader in biosimulation, today announced the addition of Carol Gallagher, Pharm.D., to its board of directors.  Dr. Gallagher is an experienced biopharmaceutical director and operator and serves as a venture … Continued

サターラ、William Blair Growth Stock ConferenceとJefferies Virtual Healthcare Conferenceに参加

PRINCETON, N.J.—2021年5月20日– Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in biosimulation, today announced that William Feehery, Chief Executive Officer, and Andrew Schemick, Chief Financial Officer, will participate in the following virtual investor conferences: Fireside Chat on Tuesday, June 1st at 11:40 a.m. ET Fireside Chat on Friday, June 4th at 10:00 a.m. ET … Continued

Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance

PRINCETON, N.J.—May. 6, 2021– Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2021. Highlights: Revenue was $66.7 million, representing growth of 16% over the first quarter of 2020. Net income was $1.1 million, compared to a net income of $1.0 million in … Continued

Certara to Present at the BofA Securities 2021 Virtual Health Care Conference

2021年4月30日ニュージャージー州プリンストン - バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in biosimulation, today announced that it will be participating in the BofA Securities 2021 Virtual Health Care Conference. William Feehery, CEO, and Andrew Schemick, CFO, are scheduled to present on 2021年5月11日 (火曜日) at 2:45 p.m. ET.  A live webcast will … Continued

Certara to Report Preliminary First Quarter 2021 Financial Results on 2021年5月6日

PRINCETON, N.J.— 2021年4月22日– Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT) はCERT), a global leader in biosimulation, today announced that it will release preliminary financial results for the first quarter of 2021 after the market close on 2021年5月6日 (木曜日). Company management will host a conference call to discuss financial results at 5:00 p.m. ET. Investors interested … Continued

2 of 4
Powered by Translations.com GlobalLink OneLink Software